Decoding the B cell endotype in early onset type 1 diabetes
解读早发 1 型糖尿病中的 B 细胞内型
基本信息
- 批准号:10294155
- 负责人:
- 金额:$ 14.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:10 year old18 year oldAffinityAgeAge of OnsetAntibodiesAntigen-Presenting CellsAntigensAutoantibodiesAutoimmune DiseasesAutoimmunityB-Lymphocyte SubsetsB-LymphocytesBar CodesBeta CellBindingBloodCD86 geneCell CompartmentationCellsCytometryDevelopmentDiabetes autoantibodiesDiagnosisDiseaseDisease ProgressionExhibitsFrequenciesFutureGoalsHyperglycemiaIndividualInflammationInsulinInsulin-Dependent Diabetes MellitusLeftMediatingMemoryMolecularOrgan DonorPancreasPathogenesisPathogenicityPatientsPeripheral Blood Mononuclear CellPhenotypePlasmablastPlayPopulationPrediabetes syndromeProductionReportingRiskRoleSamplingSignal TransductionSiteSpleenStainsStructure of beta Cell of isletStudy SubjectT-LymphocyteTNFRSF6 geneTherapeuticWorkage groupage relatedautoreactive B cellautoreactive T cellearly onsetfunctional statusgenetic signaturehigh dimensionalityhigh riskinsightinsulin dependent diabetes mellitus onsetisletlymph nodesoffenderperipheral bloodpreventresponserituximabtherapeutic targettranscriptome sequencingtype I diabetic
项目摘要
Project Summary/Abstract
Type 1 diabetes (T1D) is an autoimmune disorder characterized by destruction of the pancreatic beta
cells, leading to decreased production of insulin and hyperglycemia. Although T cells are the primary effectors
of beta cell destruction in T1D, autoreactive B cells are thought to be essential contributors as antigen
presenting cells. Moreover, recent findings indicate that B cells appear to play a more pathogenic role in
individuals who develop T1D at an earlier age. Studies have shown that young onset T1D subjects have
increased B cells in their blood and an increased frequency of B cells in their pancreas compared to later onset
T1D subjects. Importantly, this age-specific B cell signature is also associated with rapid progression of
disease. Despite the recent evidence for B cell participation in a more aggressive form of disease, little is
known regarding the phenotype and function of B cells in subjects at different ages of onset. Recently we
developed a robust 38+ B cell panel for high dimensional single-cell mass cytometry to simultaneously identify
total and insulin-reactive B cells, the various B cell subpopulations, and their activation and functional status,
allowing for a more granular characterization of B cells. Using this comprehensive B cell panel, in aim 1 we will
determine whether a specific B cell subset / phenotype exists in the peripheral blood of young onset T1D
subjects and a portion of at-risk autoantibody positive prediabetics, which could explain their rapid progression
of disease. In aim 2 we will compare the B cell population in paired spleen and pancreatic lymph node samples
from early onset, late onset, and control organ donors to determine whether a specific B cell subset has
migrated from the periphery (spleen) to the site of inflammation (pancreatic lymph node). The potential impact
of these studies lies in identification of the pathogenic B cell(s) responsible for the rapid progression of
disease, which will inform our understanding of the aggressiveness of early onset T1D and increase the
precision of future age appropriate therapeutics.
项目概要/摘要
1 型糖尿病 (T1D) 是一种自身免疫性疾病,其特征是胰腺 β 细胞破坏
细胞,导致胰岛素产生减少和高血糖。尽管T细胞是主要效应器
自身反应性 B 细胞被认为是 T1D 中 β 细胞破坏的重要贡献者
呈现细胞。此外,最近的研究结果表明,B 细胞似乎在
较早患上 T1D 的人。研究表明年轻发病的 T1D 受试者
与发病较晚的患者相比,血液中的 B 细胞增多,胰腺中 B 细胞的频率增加
T1D 科目。重要的是,这种年龄特异性 B 细胞特征还与疾病的快速进展相关。
疾病。尽管最近有证据表明 B 细胞参与了一种更具侵袭性的疾病,但很少有证据表明 B 细胞参与了一种更具侵袭性的疾病。
已知不同发病年龄受试者的 B 细胞表型和功能。最近我们
开发了强大的 38+ B 细胞面板,用于高维单细胞质谱流式分析,以同时识别
总 B 细胞和胰岛素反应性 B 细胞、各种 B 细胞亚群及其激活和功能状态,
允许对 B 细胞进行更精细的表征。使用这个全面的 B 细胞组,在目标 1 中,我们将
确定年轻发病 T1D 的外周血中是否存在特定的 B 细胞亚群/表型
受试者和部分高危自身抗体阳性前驱糖尿病患者,这可以解释他们的快速进展
的疾病。在目标 2 中,我们将比较配对的脾脏和胰腺淋巴结样本中的 B 细胞群
从早发、晚发和对照器官捐献者中确定特定 B 细胞亚群是否具有
从外周(脾脏)迁移到炎症部位(胰腺淋巴结)。潜在影响
这些研究的重点在于鉴定导致疾病快速进展的致病性 B 细胞。
疾病,这将有助于我们了解早发型 T1D 的侵袭性,并增加
适合未来年龄的治疗的精确度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mia Smith其他文献
Mia Smith的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mia Smith', 18)}}的其他基金
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10178141 - 财政年份:2020
- 资助金额:
$ 14.72万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10055413 - 财政年份:2020
- 资助金额:
$ 14.72万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10431828 - 财政年份:2020
- 资助金额:
$ 14.72万 - 项目类别:
Genetic contribution to loss of B cell anergy during development of type 1 diabetes
1 型糖尿病发展过程中 B 细胞无反应性丧失的遗传因素
- 批准号:
10647749 - 财政年份:2020
- 资助金额:
$ 14.72万 - 项目类别:
Genetic risk alleles as drivers of loss of anergic B cells in autoimmunity
遗传风险等位基因是自身免疫中无能 B 细胞丧失的驱动因素
- 批准号:
9305774 - 财政年份:2016
- 资助金额:
$ 14.72万 - 项目类别:
相似国自然基金
12-18岁正常及特发性脊柱侧凸胸腰段三维数字化临床解剖学研究
- 批准号:81460330
- 批准年份:2014
- 资助金额:49.0 万元
- 项目类别:地区科学基金项目
利用多元影像学技术构建中国18周岁汉族青少年骨龄评价指标体系
- 批准号:81373252
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
中国9- - 18岁城市学生攻击行为评定常模研制及攻击个体社会认知的fMRI研究
- 批准号:30972496
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
- 批准号:
10279706 - 财政年份:2021
- 资助金额:
$ 14.72万 - 项目类别:
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
- 批准号:
10693288 - 财政年份:2021
- 资助金额:
$ 14.72万 - 项目类别:
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
提高急性淋巴细胞白血病儿科患者外周血微小残留病监测的敏感性
- 批准号:
10020337 - 财政年份:2019
- 资助金额:
$ 14.72万 - 项目类别:
Increased sensitivity of minimal residual disease monitoring using peripheral blood in pediatric patients with acute lymphoblastic leukemia
提高急性淋巴细胞白血病儿科患者外周血微小残留病监测的敏感性
- 批准号:
10012271 - 财政年份:2019
- 资助金额:
$ 14.72万 - 项目类别:
Developing an Automated Symptom Monitoring Device for Adolescents with Asthma
开发针对青少年哮喘的自动症状监测设备
- 批准号:
8308983 - 财政年份:2009
- 资助金额:
$ 14.72万 - 项目类别: